Progress of implementation of the World Health Organization strategy for HIV drug resistance control in Latin America and the Caribbean

Simple item page
dc.contributor.authorRavasi, Giovanni
dc.contributor.authorJack, Nicola
dc.contributor.authorAlonso Gonzalez, Maria
dc.contributor.authorSued, Omar
dc.contributor.authorPérez-Rosales, Marcelo D.
dc.contributor.authorGomez, Blanca
dc.contributor.authorVila, Marcos
dc.contributor.authorRiego, Adrian
dc.contributor.authorGhidinelli, Marcelo
dc.date.accessioned2024-05-23T18:53:33Z
dc.date.available2024-05-23T18:53:33Z
dc.date.issued2011
dc.description.abstractBy the end of 2010, Latin America and the Caribbean (LAC) achieved 63% antiretroviral treatment (ART) coverage. Measures to control HIV drug resistance (HIVDR) at the countrylevel are recommended to maximize the efficacy and sustainability of ART programs. Since 2006, the Pan American Health Organization has supported implementation of the WorldHealth Organization (WHO) strategy for HIVDR prevention and assessment through regional capacity-building activities and direct technical cooperation in 30 LAC countries. By 2010, 85 sites in 19 countries reported early warning indicators, providing information about the extent of potential drivers of drug resistance at the ART site. In 2009, 41.9% of sites did notachieve the WHO target of 100% appropriate first-line prescriptions; 6.3% still experienced high rates ( 20%) of loss to follow-up, and 16.2% had low retention of patients ( 70%) on first-line prescriptions in the first year of treatment. Stock-outs of antiretroviral drugs occurred at 22.7% of sites. Haiti, Guyana, and the Mesoamerican region are planning and implementing WHO HIVDR monitoring surveys or threshold surveys. New HIVDR surveillance tools for concentrated epidemics would promote further scale-up. Extending the WHO HIVDR lab network in Latin America is key to strengthening regional lab capacity to support quality assuredHIVDR surveillance. The WHO HIVDR control strategy is feasible and can be rolled out in LAC. Integrating HIVDR activities in national HIV care and treatment plans is key to ensuring the sustainability of this strategy.(AU)
dc.identifier.citationRavasi G, Jack N, Alonso Gonzalez M, Sued O, Pérez-Rosales MD, Gomez B, et al. Progress of implementation of the World Health Organization strategy for HIV drug resistance control in Latin America and the Caribbean. Rev Panam Salud Publica. 2011;30(6):657–62.
dc.identifier.otherDOI: 10.1590/S1020-49892011001200026
dc.identifier.otherhttps://iris.paho.org/handle/10665.2/9401
dc.identifier.urihttps://repositorio.huesped.org.ar/handle/123456789/1089
dc.relation.ispartofseriesRevista Panamericana de Salud Pública
dc.subjectWorld Health Organization strategy
dc.subjectHIV drug resistance control
dc.subjectLatin America and the Caribbean
dc.titleProgress of implementation of the World Health Organization strategy for HIV drug resistance control in Latin America and the Caribbean

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
136_2011_Ravasi_Progress of implementation of the World Health Organization strategy for HIV drug resistance control in Latin America and the Caribbean.pdf
Size:
199.78 KB
Format:
Adobe Portable Document Format
Download

Collections

Articulos científicos